Cargando…

t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

Detalles Bibliográficos
Autores principales: Narita, T, Inagaki, A, Kobayashi, T, Kuroda, Y, Fukushima, T, Nezu, M, Fuchida, S, Sakai, H, Sekiguchi, N, Sugiura, I, Maeda, Y, Takamatsu, H, Tsukamoto, N, Maruyama, D, Kubota, Y, Kojima, M, Sunami, K, Ono, T, Ri, M, Tobinai, K, Iida, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349263/
https://www.ncbi.nlm.nih.gov/pubmed/25723856
http://dx.doi.org/10.1038/bcj.2015.6
_version_ 1782360020088782848
author Narita, T
Inagaki, A
Kobayashi, T
Kuroda, Y
Fukushima, T
Nezu, M
Fuchida, S
Sakai, H
Sekiguchi, N
Sugiura, I
Maeda, Y
Takamatsu, H
Tsukamoto, N
Maruyama, D
Kubota, Y
Kojima, M
Sunami, K
Ono, T
Ri, M
Tobinai, K
Iida, S
author_facet Narita, T
Inagaki, A
Kobayashi, T
Kuroda, Y
Fukushima, T
Nezu, M
Fuchida, S
Sakai, H
Sekiguchi, N
Sugiura, I
Maeda, Y
Takamatsu, H
Tsukamoto, N
Maruyama, D
Kubota, Y
Kojima, M
Sunami, K
Ono, T
Ri, M
Tobinai, K
Iida, S
author_sort Narita, T
collection PubMed
description
format Online
Article
Text
id pubmed-4349263
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43492632015-03-10 t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs Narita, T Inagaki, A Kobayashi, T Kuroda, Y Fukushima, T Nezu, M Fuchida, S Sakai, H Sekiguchi, N Sugiura, I Maeda, Y Takamatsu, H Tsukamoto, N Maruyama, D Kubota, Y Kojima, M Sunami, K Ono, T Ri, M Tobinai, K Iida, S Blood Cancer J Letter to the Editor Nature Publishing Group 2015-02 2015-02-27 /pmc/articles/PMC4349263/ /pubmed/25723856 http://dx.doi.org/10.1038/bcj.2015.6 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Narita, T
Inagaki, A
Kobayashi, T
Kuroda, Y
Fukushima, T
Nezu, M
Fuchida, S
Sakai, H
Sekiguchi, N
Sugiura, I
Maeda, Y
Takamatsu, H
Tsukamoto, N
Maruyama, D
Kubota, Y
Kojima, M
Sunami, K
Ono, T
Ri, M
Tobinai, K
Iida, S
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title_full t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title_fullStr t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title_full_unstemmed t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title_short t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
title_sort t(14;16)-positive multiple myeloma shows negativity for cd56 expression and unfavorable outcome even in the era of novel drugs
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349263/
https://www.ncbi.nlm.nih.gov/pubmed/25723856
http://dx.doi.org/10.1038/bcj.2015.6
work_keys_str_mv AT naritat t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT inagakia t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT kobayashit t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT kuroday t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT fukushimat t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT nezum t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT fuchidas t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT sakaih t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT sekiguchin t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT sugiurai t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT maeday t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT takamatsuh t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT tsukamoton t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT maruyamad t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT kubotay t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT kojimam t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT sunamik t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT onot t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT rim t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT tobinaik t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs
AT iidas t1416positivemultiplemyelomashowsnegativityforcd56expressionandunfavorableoutcomeevenintheeraofnoveldrugs